1. Home
  2. AP vs BTAI Comparison

AP vs BTAI Comparison

Compare AP & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ampco-Pittsburgh Corporation

AP

Ampco-Pittsburgh Corporation

HOLD

Current Price

$8.94

Market Cap

138.0M

Sector

Industrials

ML Signal

HOLD

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$1.59

Market Cap

36.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AP
BTAI
Founded
1929
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
36.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AP
BTAI
Price
$8.94
$1.59
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$26.67
AVG Volume (30 Days)
331.4K
296.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$261.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$1.17
52 Week High
$9.69
$8.08

Technical Indicators

Market Signals
Indicator
AP
BTAI
Relative Strength Index (RSI) 62.76 45.49
Support Level $2.39 $1.50
Resistance Level N/A $1.72
Average True Range (ATR) 0.74 0.10
MACD 0.01 0.01
Stochastic Oscillator 70.85 24.53

Price Performance

Historical Comparison
AP
BTAI

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: